Tonix Pharmaceuticals Holding (TNXP) Deferred Taxes (2011 - 2016)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Deferred Taxes of -$9000.0 for Q1 2016, down 350.0% year-over-year from $3600.0 in Q2 2015, and down 120.0% quarter-over-quarter from $45000.0 in Q4 2015.
Tonix Pharmaceuticals Holding (TNXP) Deferred Taxes (2011 - 2016) Analysis & Trends
Tonix Pharmaceuticals Holding's Deferred Taxes history runs 6 years deep, the most recent figure standing at -$9000.0 for Q1 2016.
- In Q1 2016, Deferred Taxes fell 350.0% year-over-year to -$9000.0; the TTM figure through Mar 2016 stood at $47000.0 (down 14.55% YoY), while the FY2015 annual figure was $54000.0, down 1.82% from the prior year.
- Deferred Taxes for Q1 2016 stood at -$9000.0, down from $45000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $47000.0 in Q3 2014, with the low at -$9000.0 in Q1 2016.
- The 5-year median for Deferred Taxes is -$1000.0 (2013), against an average of $5294.1.
- The sharpest annual moves came in 2014 and 2016: Deferred Taxes surged 4800.0% in 2014, then slumped 350.0% in 2016.
- Tonix Pharmaceuticals Holding's Deferred Taxes stood at -$1460.0 in 2012, then plunged by 105.48% to -$3000.0 in 2013, then soared by 400.0% to $9000.0 in 2014, then soared by 400.0% to $45000.0 in 2015, then slumped by 120.0% to -$9000.0 in 2016.
- Business Quant data shows TNXP's Deferred Taxes at -$9000.0 in Q1 2016, $45000.0 in Q4 2015, and $12000.0 in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | -9,000.00 |
| Dec 31, 2015 | 45,000.00 |
| Sep 30, 2015 | 12,000.00 |
| Jun 30, 2015 | -1,000.00 |
| Mar 31, 2015 | -2,000.00 |
| Dec 31, 2014 | 9,000.00 |
| Sep 30, 2014 | 47,000.00 |
| Jun 30, 2014 | 1,000.00 |
| Mar 31, 2014 | -2,000.00 |
| Dec 31, 2013 | -3,000.00 |
| Sep 30, 2013 | -1,000.00 |
| Jun 30, 2013 | -2,000.00 |
| Mar 31, 2013 | -1,000.00 |
| Dec 31, 2012 | -1,460.00 |
| Sep 30, 2012 | -513.00 |
| Jun 30, 2012 | -514.00 |
| Mar 31, 2012 | -513.00 |
| Dec 31, 2011 | -514.00 |
| Sep 30, 2011 | 334.00 |
| Jun 30, 2011 | 334.00 |